video: Paradigm Shifting to Thrive Despite Having Multiple Sclerosis
Dr.B discusses the concept of “Paradigm Shifting” to thrive despite having Multiple Sclerosis MS Views and News is MAKING an IMPACT for…
What is “Therapeutic Lag”? Why does it matter when treating Multiple Sclerosis?
Dr.B discusses the concept of therapeutic lag and its relevance when assessing the efficacy of MS disease modifying therapies. MS…
Stuart Schlossman
“Down There” — Sexual Dysfunction in Multiple Sclerosis
Aaron Boster MD Published on Nov 7, 2017 Dr.B discusses sexual dysfunction in Multiple Sclerosis MS Views and News is MAKING…
Stuart Schlossman
A goal of MS therapy: slowing the rate of brain atrophy (shrinkage)!
MS brains atrophy (shrink) at a faster rate than non-MS brains (up to 10 times faster!). It should be our…
Stuart Schlossman
Dr.B offers his opinion regarding alemtuzumab
WATCH, Listen, Learn and share this expert opinion with others MS Views and News is MAKING an IMPACT for those, affected by…
Stuart Schlossman
Confirmed Disability Improvement (CDI) in Multiple Sclerosis
MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis MS Views and News provides beneficial Multiple Sclerosis…
Stuart Schlossman
Learn information concerning the new diagnostic criteria of #MS
LISTEN to this video by Aaron Boster, MD — https://t.co/BuRcWBVeM7 then share the intellectual conversation regarding Diagnostic Criteria of Multiple…
Stuart Schlossman
No Evidence Of Disease Activity (NEDA) as a goal of MS treatment
Aaron Boster MD Published on Sep 30, 2017 Dr. B shares his opinions on No Evidence of Disease Activity (NEDA)…
Stuart Schlossman
Cognitive Fatigue in Multiple Sclerosis
…
Stuart Schlossman
When to obtain an MRI, in a Lemtrada treated Person with MS
…
Stuart Schlossman
